Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?

Author： Maes Michael Anderson George Kubera Marta Berk Michael

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.18, Iss.5, 2014-05, pp. : 495-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Novel therapy for Crohn’s disease targeting IL-6 signalling

By Ito Hiroaki

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 4, 2004-08 ,pp. : 287-294

Informa Healthcare

Access to resources Recommend Favorite

Targeting IL-8 signalling to inhibit breast cancer stem cell activity

By Singh Jagdeep K Simões Bruno M Clarke Robert B Bundred Nigel J

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1235-1241

Informa Healthcare

Access to resources Recommend Favorite

Hitting a complex target: an update on interleukin-6 trans-signalling

By Waetzig Georg H Rose-John Stefan

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 225-236

Informa Healthcare

Access to resources Recommend Favorite

Targeting IL-1 in depression

By Maes Michael Song Cai Yirmiya Raz

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1097-1112

Informa Healthcare

Access to resources Recommend Favorite

IL-6 and Crohn's Disease

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 125-130

Bentham Science Publishers

Access to resources Recommend Favorite